Therapeutic Efficacy of a Bivalent Inhibitor of Prostate-Specific Membrane Antigen Labeled with 67Cu-Reference-Cited by-同舟云学术

Therapeutic Efficacy of a Bivalent Inhibitor of Prostate-Specific Membrane Antigen Labeled with 67Cu

Published:2020-10-16 Issue:6 Volume:62 Page:829-832
ISSN:0161-5505
Container-title:Journal of Nuclear Medicine
language:en
Short-container-title:J Nucl Med

Author:

McInnes Lachlan E.,Cullinane Carleen,Roselt Peter D.,Jackson Susan,Blyth Benjamin J.,van Dam Ellen M.,Zia Nicholas A.,Harris Matthew J.,Hicks Rodney J.,Donnelly Paul S.

Publisher

Society of Nuclear Medicine

Subject

Radiology Nuclear Medicine and imaging

Reference17 articles.

1. Isolation and Expression of Novel Human Glutamate Carboxypeptidases with N-Acetylated α-Linked Acidic Dipeptidase and Dipeptidyl Peptidase IV Activity

2. The Rise of PSMA Ligands for Diagnosis and Therapy of Prostate Cancer

3. Design of Remarkably Simple, Yet Potent Urea-Based Inhibitors of Glutamate Carboxypeptidase II (NAALADase)

4. Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study;Hofman;Lancet.,2020

5. 68Ga- and 177Lu-Labeled PSMA I&T: Optimization of a PSMA-Targeted Theranostic Concept and First Proof-of-Concept Human Studies

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Alpha and Beta Radiation for Theragnostics;PET Clinics;2024-07

2. Copper and Copper Complexes in Tumor Therapy;ChemMedChem;2024-03-22

3. Application of Advanced Imaging to Prostate Cancer Diagnosis and Management: A Narrative Review of Current Practice and Unanswered Questions;Journal of Clinical Medicine;2024-01-13

4. ¹⁷⁷Lu-Labeled Bivalent Ligands of Prostate-Specific Membrane Antigen for Endoradiotherapy of Prostate Cancer;Molecular Pharmaceutics;2023-12-28

5. Theranostic Nuclear Medicine with Gallium-68, Lutetium-177, Copper-64/67, Actinium-225, and Lead-212/203 Radionuclides;Chemical Reviews;2023-10-05